Swedish Orphan Biovitrum total depreciation and amortization - cash flow for the twelve months ending September 30, 2024 was $0.823B, a 29.9% increase year-over-year.
Swedish Orphan Biovitrum annual total depreciation and amortization - cash flow for 2023 was $0.302B, a 25.88% increase from 2022.
Swedish Orphan Biovitrum annual total depreciation and amortization - cash flow for 2022 was $0.24B, a 2.49% increase from 2021.
Swedish Orphan Biovitrum annual total depreciation and amortization - cash flow for 2021 was $0.234B, a 6.07% increase from 2020.
Swedish Orphan Biovitrum Total Depreciation and Amortization - Cash Flow 2019-2024 | BIOVF